Article information
Full text is only aviable in PDF
BIBILIOGRAFIA
[1.]
M.G. Arrigoni, L.B. Woolner, P.E. Bernatz.
Atypical carcinoid tumors of the lung.
J Thorac Cardiovasc Surg, 64 (1972), pp. 413-421
[2.]
R. Azeved–Bernarda.
Avanços técnicos na caracterização do cancro do pulmão.
Via Pneumológica, 2 (1992), pp. 139-143
[3.]
S.E. Bates.
Clinical applications of serum tumor markers.
Annals Intern Med, 115 (1991), pp. 623-638
[4.]
G. Bepler, K. Neumann, Holler, K. Havemann, H. Kalbfleisch.
Clinical relevance of histologic subtyping in small cell lung cancer.
Cancer, 64 (1989), pp. 74-79
[5.]
O.C. Burg Huber, et al.
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Cancer, 65 (1990), pp. 1386-1390
[6.]
J. Carles, et al.
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Lung Cancer, 10 (1993), pp. 209-219
[7.]
D.N. Carney, A.F. Gazdar, M. Nau, J.D. Minna.
Biological heterogeneity of small cell lung cancer.
Semin Oncol, 12 (1985), pp. 289-303
[8.]
D.N. Carney, P.J. Marangos, D.C. Ihde, et al.
Serum neuronspecific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Lancet, I (1982), pp. 583-585
[9.]
L.F. Decaro, R. Paladugu, J.R. Bebfield, L. LoVisatti, H. Pak, R.L. Teplitz.
Typical and atypical carcinoids within the pulmonary APUD tumor spectrum.
J Thorac Cardiovasc Surg, 86 (1983), pp. 528-536
[10.]
R. Feld, R. Arriagada, D.L. Ball, K. Mattson, J.B. Sørensen.
Prognostic factors in non-small cell lung cancer: a consensus report.
Lung Cancer, 7 (1991), pp. 3-5
[11.]
A.F. Gazdar.
Pathology’s impact on lung cancer management.
Contemporany Oncology, Summer, (1994), pp. 3-35
[12.]
A.F. Gazdar, D.N. Carney.
pp. 4
[13.]
A.F. Gazdar, E.M. McDowell.
Pathobiology of lung cancers.
pp. 1-42
[14.]
G. Gomez, G. Estrada, C.F. Leon.
Tumor carcinoide bronquial.
Arch Bronconeumol, 21 (1985), pp. 217-224
[15.]
V.E. Gould.
The dispersed neuroendocrine system and its components in the bronchial tree.
Acta Med Port, 5 (1984), pp. 39-41
[16.]
V.E. Gould, W.H. Warren.
Neuroendocrine neoplasms of the bronchopulmonary tract.
Lung Cancer, (1994), pp. 199-200
[17.]
S.L. Graziano, R. Mazid, N. Newman, et al.
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer.
J Clin Oncol, 7 (1989), pp. 1398-1406
[18.]
R.S. Greenberg, D.A. Baumgarten, W.S. Clark, P. Isacson, K. Mckeen.
Prognostic factors for gastro-intestinal and bronchopulmonary carcinoid tumors.
Cancer, 60 (1987), pp. 2476-2483
[19.]
T.H. Grote, W.R. Macon, B. Davls, F.A. Greco, H. Johnson.
Atypical carcinoid of the lung A distinct clinopathologic entity.
Chest, 93 (1988), pp. 370-375
[20.]
F.R. Hirsch.
The clinical implication of neuroendocrine markers in non-small cell lung cancer.
Lung Cancer, 11 (1994), pp. 201-202
[21.]
F.R. Hirsch, Matthews, S. Aisner, O. Compo Basso, J.D. Elema, A.F. Gazdar, B. MacKay, M. Nasiell, Y. Shimosato, R.H. Steele.
Histopathologic classification of small cell lung cancer. Changing concepts and terminology.
Cancer, 62 (1988), pp. 973-977
[22.]
F.R. Hirsch, K. Østerlind, H.H. Hansen.
The prognostic significance of histopathologic subtyping of small carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients.
Cancer, 52 (1983), pp. 2144-2150
[23.]
F.R. Hirsch, K. Rygaard.
The role of the pathologist in the management of lung cancer in the 90’s.
Lung Cancer, 9 (1993), pp. 111-118
[24.]
F.R. Hirsch, B.G. Skov.
Neuroendocrine characteristics in bronchogenic adenocarcinoma and its clinical relevance.
Lung Cancer, 9 (1993), pp. 89-96
[25.]
K. Karrer, T.W. Shields, H. Denk, B. Hraber, I. Vogt-Moykopf, G.M. Salzer.
The imponance of surgical and multimodality treatment for small cell bronchial carcinoma.
J Thorac Cardiovasc Surg, 97 (1989), pp. 168-176
[26.]
K. Kayser, H.-J. Gabius, A. Kohler, T. Runtsch.
Bindind of neuroendocrine markers and biotinylated sex hormones and the survival in human lung cancer.
Lung Cancer, 6 (1990), pp. 171-183
[27.]
H. Kreisman, N. Wolkove, E. Quoix.
Small cell lung cancer presenting as a solitary pulmonary nodule.
Chest, 101 (1992), pp. 225-231
[28.]
J.A. Lederman.
Biological approaches to the therapy of lung cancer.
ESMO, (1994), pp. 67-71
[29.]
R. Lima.
Bronchial adenoma. Clinicopathologic study and results of treatment.
Chest, 77 (1980), pp. 81-84
[30.]
I. Linnoila.
Pathology of non-small cell lung cancer New diagnostic approaches.
Hemat/ Oncol Clinics North America, 4 (1990), pp. 1027-1051
[31.]
S. Lyubsky, M.J. Jacobson.
Lung cancer: making the diagnosis.
Chest, 100 (1991), pp. 511-520
[32.]
B.C. Mccaughan, N. Martini, M.S. Bains.
Bronchial carcinoids: Review of 124 cases.
J Thorac Cardiovasc Surg, 89 (1985), pp. 8-17
[33.]
P.A. McCue, G.C. Finkel.
Small-cell lung carcinoma: an evolving histopathological spectrum.
Semin Oncol, 20 (1993), pp. 153-162
[34.]
W.J. Mooi, K.P. Dingemans, N. Van Zandwijk.
Prevalence of neuroendocrine granules in small cell lung carcinoma. Usefulness of electron microscopy in lung cancer classification.
J Pathol, 149 (1986), pp. 41-47
[35.]
W.J. Mooi, N. Van Zandwijk, K. Dingmans, et al.
The “grey area” between small-cell and non-small cell carcinomas. Light and electron microscopy versus clinical data in 14 cases.
J Pathol, 149 (1986), pp. 49-54
[36.]
L. Mosca, A. Ceresoli, E. Anzanello, et al.
Neuroendocrine structures in normal and diseased buman lung.
Applied Pathology, 4 (1986), pp. 147-161
[37.]
L.C. Müller, R. Gasser, H. Huber, A. Klingler, G.M. Salzer.
Neuron-specific enolase (NSE) in small-cell lung cancer: longitudinal tumor marker evaluation.
Lung Cancer, (1992), pp. 29-36
[38.]
I. Norheim, et al.
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production. and survival.
Ann Surg, 206 (1987), pp. 115-125
[39.]
U. Pal, K. Frigyes, C. Attila.
Surgical treatment of bronchial carcinoid tumours.
Radical surgery-prognosis, Int Surg, 76 (1991), pp. 98.100
[40.]
R.R. Paladugu, J.R. Benfield, H.V. Pak, R.K. Ross, R.L. Teplttz.
Bronchopulmonary Kulschttzki cell carcinomas: a new classification scheme of typical and atypical carcinoids.
Cancer, 55 (1985), pp. 1303-1311
[41.]
P.A. Race, et al.
The clinical behavior of “mixed” small cell/ large cell bronchogenic carcinoma compared to “pure” small cell subtypes.
Cancer, 50 (1982), pp. 2894-2902
[42.]
G.E. Richardson, B.E. Johnson.
The biology of lung cancer.
Semin Oncol, 20 (1993), pp. 105-127
[43.]
A.J.A. Robalo Cordeiro.
Marcadores bioquímicos do carcinoma brônquico.
Via Pneumológica, 1 (1992), pp. 17-29
[44.]
V.S. Salminen, P.E. Halitunen, S.P. Mattila, A. Sahlman, M. Miettinen.
Bronchial carcinoid: A clinical follow-up study of 33 cases.
Scand J Thorac Cardiovasc Surg, 25 (1991), pp. 189-194
[46.]
F.A. Shepherd, R.J. Ginsberg, G.A. Patterson, W.K. Evans, R. Feld, et al.
A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group Study.
J Thorac Cardiovasc Surg., 97 (1989), pp. 177-186
[47.]
M.N. Sheppard.
Neuroendocrine differentiation in lung tumours.
Thorax, 46 (1991), pp. 843-850
[48.]
M.N. Sheppard.
Immunohistochemistry and in situ hybridisation in the diagnosis and prognosis of lung cancer.
Lung Cancer, 9 (1993), pp. 119-134
[49.]
M.N. Sheppard.
Neuroendocrine differentation in lung tumours.
pp. 30-50
[50.]
R. Sotto-Mayor.
Heterogeneidade tumoral.
pp. 37-44
[51.]
R. Sotto-Mayor, J. Carvalhal, J. Valença, E. Teixeira, J. Maçanita, M. Freitas E Costa.
A importância do antigénio carcino-embriornário (CEA) e da neuro-enolase específica (NSE) no diagnóstico e no estadiamento do cancro do pulmão.
Via Pneumológica, III (1990), pp. 25-34
[52.]
R. Sotto-Mayor, J. Maçanita, M. Freitas E Costa.
Tumores broncopulmonares berugnos. Experiência da Clinica de Doenças Pulmonares da Faculdade de Medicina de Lisboa.
Arq SPPR, IV (1987), pp. 29-35
[53.]
G.M. Strauss, A.T. Skarin.
Use of tumor markers in lung cancer.
Hemat/ Oncol Clinics North America, 8 (1994), pp. 507-532
[54.]
M. Szturmowicz, et al.
Prognostic value of neuron -speficic enolase in small cell lung cancer patients.
Lung Cancer, 8 (1993), pp. 259-264
[55.]
M.E. Teeling, D.N. Carney.
Biochemical markers of lung cancer.
pp. 43-58
[56.]
F. Thomas, R. Arriagada, T. Le Chevalier, M.F. Poupon.
Progrès réccnts dans la biologic du carcinome bronchique à petites cellules.
Rev Mal Resp, 5 (1988), pp. 451-461
[57.]
W.D. Travis.
Classification of neuroendocrine tumors of the lung.
Lung Cancer, II (1994), pp. 197-198
[58.]
W.D. Travis, et al.
Neuroendocrine tumours of the lung with proposed criteria for large cell neuroendocrine carcinoma.
Am J Surg Pathol, 15 (1991), pp. 529-553
[59.]
E. Ulsperger, T. Shields, K. Karrer.
The role of surgery in small cell lung cancer.
Lung Cancer, 6 (1990), pp. 73-83
[60.]
W.H. Warren, L.P. Faber, V.E. Gould.
Neuroendocrine neoplasms of the lung. A clinicopathologic update.
J Thorac Cardiovasc Surg, 98 (1989), pp. 321-332
[61.]
W.H. Warren, V.E. Gould.
Long term follow-up of classical bronchial carcinoid tumours. Clinicopathologic observations.
Scand J Thorac Cardiovasc Surg, 24 (1990), pp. 125-130
[62.]
W.H. Warren, V.E. Gould, L.P. Farber, C.F. Kiitle, V.A. Memoli.
Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervenig variants.
J Thorac Cardiovasc Surg, 89 (1985), pp. 819-825
[63.]
W.H. Warren, V.A. Memoli, A.G. Jordan, V.E. Gould.
Reevaluation of pulmonary neoplasms rsected as small cell carcinomas. Significance of distinguishing between well-differentiated and small cell neuroendocrine carcinomas.
Cancer, 65 (1990), pp. 1003-1010
[64.]
E.D. Williams, L.R. Celestin.
The association of bronchial carcinoid and pluriglandular adenomatosis.
Thorax, 31 (1962), pp. 212-219
[65.]
The World Health Organization Histological Typing of Lung Tumors, 2nd ed.
Am J Clin Pathol, 77 (1982), pp. 123-136
[66.]
R. Yesner.
Pathogenesis and pathology.
Clinics Chest Med, 14 (1993), pp. 17-30
Copyright © 1995. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options